Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.7.3.391
Reference38 articles.
1. Estimating the world cancer burden: Globocan 2000
2. Cancer burden in the year 2000. The global picture
3. Worldwide burden of gynaecological cancer: The size of the problem
4. Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost
5. Human papillomavirus in cervical cancer
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanotechnology in vaccines and personalized medicine;Comprehensive Precision Medicine;2024
2. Cytologic Monitoring, Management of Cervical Cancer, and Control of Human Papillomavirus;Cervical Cancer - Recent Advances and New Perspectives;2023-12-27
3. Knowledge of HPV and HPV Vaccination among Polish Students from Medical and Non-Medical Universities;Vaccines;2023-12-14
4. Effect of HPV Vaccination on Virus Disappearance in Cervical Samples of a Cohort of HPV-Positive Polish Patients;Journal of Clinical Medicine;2023-12-09
5. Validation of Luminex immunological and competitive Luminex immunological assays for clinical immunogenicity assessment of a 14‐valent recombinant human papillomavirus vaccine;Journal of Medical Virology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3